全文获取类型
收费全文 | 152113篇 |
免费 | 15698篇 |
国内免费 | 4787篇 |
专业分类
耳鼻咽喉 | 1380篇 |
儿科学 | 2579篇 |
妇产科学 | 1795篇 |
基础医学 | 29167篇 |
口腔科学 | 3664篇 |
临床医学 | 9684篇 |
内科学 | 22885篇 |
皮肤病学 | 3021篇 |
神经病学 | 14443篇 |
特种医学 | 3729篇 |
外国民族医学 | 43篇 |
外科学 | 12331篇 |
综合类 | 16273篇 |
现状与发展 | 14篇 |
预防医学 | 6439篇 |
眼科学 | 1705篇 |
药学 | 23648篇 |
34篇 | |
中国医学 | 5830篇 |
肿瘤学 | 13934篇 |
出版年
2023年 | 2574篇 |
2022年 | 3432篇 |
2021年 | 6038篇 |
2020年 | 5737篇 |
2019年 | 6445篇 |
2018年 | 6273篇 |
2017年 | 6181篇 |
2016年 | 5627篇 |
2015年 | 6490篇 |
2014年 | 9288篇 |
2013年 | 10043篇 |
2012年 | 8822篇 |
2011年 | 10488篇 |
2010年 | 8377篇 |
2009年 | 8360篇 |
2008年 | 8104篇 |
2007年 | 7074篇 |
2006年 | 6115篇 |
2005年 | 5371篇 |
2004年 | 4706篇 |
2003年 | 4105篇 |
2002年 | 3109篇 |
2001年 | 2594篇 |
2000年 | 2205篇 |
1999年 | 1871篇 |
1998年 | 1516篇 |
1997年 | 1558篇 |
1996年 | 1372篇 |
1995年 | 1585篇 |
1994年 | 1420篇 |
1993年 | 1286篇 |
1992年 | 1038篇 |
1991年 | 930篇 |
1990年 | 827篇 |
1989年 | 690篇 |
1988年 | 633篇 |
1987年 | 616篇 |
1986年 | 713篇 |
1985年 | 1215篇 |
1984年 | 1326篇 |
1983年 | 995篇 |
1982年 | 1006篇 |
1981年 | 879篇 |
1980年 | 755篇 |
1979年 | 633篇 |
1978年 | 431篇 |
1977年 | 357篇 |
1976年 | 383篇 |
1975年 | 301篇 |
1974年 | 214篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Research in social & administrative pharmacy》2022,18(9):3694-3698
In this paper, we argue that understanding and addressing the problem of poor-quality medical products requires a more interdisciplinary approach than has been evident to date. While prospective studies based on rigorous standardized methodologies are the gold standard for measuring the prevalence of poor-quality medical products and understanding their distribution nationally and internationally, they should be complemented by social science research to unpack the complex set of social, economic, and governance factors that underlie these patterns. In the following sections, we discuss specific examples of prospective quality surveys and of social science studies, highlighting the value of cross-sector partnerships in driving high-quality, policy-relevant research in this area. 相似文献
2.
3.
4.
5.
6.
胶质淋巴系统是一个主要由星形胶质细胞水通道蛋白4介导的依靠动脉、静脉周围血管间隙的脑脊液-脑组织液交换流动的系统,是阿尔茨海默病、脑卒中、帕金森病、失眠、抑郁症等脑病的共同特征,是一条新的脑代谢途径,可以清除包括β-淀粉样蛋白、乳酸在内的代谢产物。本文综合分析了全球有关胶质淋巴系统在脑部疾病的研究,得出:胶质淋巴系统可能为神经退行性疾病等发病机制和诊治策略研究带来新视角;胶质淋巴系统有望为一些脑部疾病诊断提供新的有效证据;胶质淋巴系统可能是脑部疾病治疗给药方式的新途径。 相似文献
7.
8.
《Digestive and liver disease》2022,54(11):1486-1493
BackgroundCold snare polypectomy (CSP) is a promising technique for the removal of sessile serrated polyps (SSPs) ≥ 10 mm. However, the efficacy and safety of this technique remain undetermined.AimsWe aimed to comprehensively evaluate the efficacy and safety of CSP for SSPs ≥ 10 mm.MethodsPubMed, EMBASE, Web of Science and Cochrane Library were searched up to January 2021.ResultsA total of 10 studies consisting of 1727 SSPs (range, 10–40 mm) from 1021 patients were included. The overall rates of technical success, adverse events (AEs) and residual SSPs were 100%, 0.7% and 2.9%, respectively. Subgroup analysis showed that the rates of technical success and AEs were comparable between CSP and cold endoscopic mucosal resection (EMR) (99.9% vs. 100% and 1.3% vs. 0.5%, respectively), between the proximal and distal colon (100% vs. 99.9% and 0.3% vs. 0, respectively), and between polyps of 10–19 mm and ≥20 mm (99.8% vs. 100% and 0.9% vs. 0, respectively). However, subgroup analysis showed that the rate of residual SSPs was slightly lower in CSP compared with cold EMR (1.3% vs. 3.9%), as well as in polyps of 10–19 mm compared with those ≥20 mm (3.1% vs. 4.7%).ConclusionCSP was an effective and safe technique for removing SSPs ≥ 10 mm. 相似文献
9.
Dong-Xin Hu Qi-Feng Sun Lin Xu Hong-Da Lu Fan Zhang Zhen-Miao Li Ming-Yan Zhang 《World journal of gastroenterology : WJG》2022,28(4):464-478
BACKGROUND Esophageal squamous cell carcinoma(ESCC)is one of the most prevalent malignancies that seriously threaten people’s health worldwide.DEAD-box helicase 51(DDX51)is a member of the DEAD-box(DDX)RNA helicase family,and drives or inhibits tumor progression in multiple cancer types.AIM To determine whether DDX51 affects the biological behavior of ESCC.METHODS The expression of DDX51 in ESCC tumor tissues and adjacent normal tissues was detected by Immunohistochemistry(IHC)analyses and quantitative PCR(qPCR).We knocked down DDX51 in ESCC cell lines by using a small interfering RNA(siRNA)transfection.The proliferation,apoptosis,and mobility of DDX51 siRNAtransfected cells were detected.The effect of DDX51 on the phosphoinositide 3-kinase(PI3K)/AKT pathway was investigated by western blot analysis.A mouse xenograft model was established to investigate the effects of DDX51 knockdown on ESCC tumor growth.RESULTS DDX51 exhibited high expression in ESCC tissues compared with normal tissues and represented a poor prognosis in patients with ESCC.Knockdown of DDX51 induced inhibition of ESCC cell proliferation and promoted apoptosis.Moreover,DDX51 siRNA-expressing cells also exhibited lower migration and invasion rates.Investigations into the underlying mechanisms suggested that DDX51 knock down induced inactivation of the PI3K/AKT pathway,including decreased phosphorylation levels of phosphate and tensin homolog,PI3K,AKT,and mammalian target of rapamycin.Rescue experiments demonstrated that the AKT activator insulin-like growth factor 1 could reverse the inhibitory effects of DDX51 on ESCC malignant development.Finally,we injected DDX51 siRNA-transfected TE-1 cells into an animal model,which resulted in slower tumor growth.CONCLUSION Our study suggests for the first time that DDX51 promotes cancer cell proliferation by regulating the PI3K/AKT pathway;thus,DDX51 might be a therapeutic target for ESCC. 相似文献
10.
《Vaccine》2022,40(32):4296-4300
Advanced computational methodologies suggested SARS-CoV-2, nonstructural proteins ORF1AB, ORF3a, as the source of immunodominant peptides for T cell presentation. T cell immunity is long-lasting and compatible with COVID-19 pathology. Based on the supporting clinical data, nonstructural SARS-CoV-2 protein vaccines could provide global immunity against COVID-19. 相似文献